Incidental lesions found in veterans referred to dermatology: The value of a dermatologic examination - 14/03/15
Abstract |
Background |
Few studies have evaluated the detection of incidental skin cancers.
Objective |
We sought to evaluate the rate of incidental cutaneous malignancies in routine dermatology consults.
Methods |
This was a retrospective chart review of all dermatology consults at the Minneapolis Department of Veterans Affairs Medical Center over 8.25 years. Inclusion criteria included an in-person clinic visit within 18 months of the initial consult date. Patients with an in-person skin examination by a dermatologist in the 18 months before consult date were excluded.
Results |
Of 28,405 consults sent during the study period, 17,174 met inclusion criteria. In all, 2257 (13.1%) patients had 1 or more biopsied incidental lesions. Half (50.3%; n = 1674) of the 3328 biopsied incidental lesions were malignant, which included 1187 patients. The per-person detection rate for an incidental malignant lesion was 6.9% (1187/17,174). There were 87 incidental melanomas identified in 84 patients. The per-person detection rate for an incidental melanoma was 0.5% (84/17,174). The most frequent anatomical location for biopsied incidental malignancies was the head and neck (53.9%). Incidental melanomas were most frequently located on the back (33.3%).
Limitations |
Nondiverse patient population and conservative detection rate estimates are limitations.
Conclusion |
An in-person skin examination by a trained dermatologist is important for detection of skin malignancies. This may have implications for teledermatology.
Le texte complet de cet article est disponible en PDF.Key words : dermatology consults, melanoma, nonmelanoma skin cancer, skin cancer, teledermatology
Abbreviations used : BIL, IPDE, PC, PCP, VA
Plan
| This material is based upon work, supported in part, by the Minneapolis Department of Veterans Affairs Medical Center. There are no other sources of funding for this work. The contents of this publication do not represent the views of the Department of Veterans Affairs or the US Government. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 72 - N° 4
P. 651 - avril 2015 Retour au numéro
Article précédent
- Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: A retrospective case series
- Murat Durdu, Deren Özcan, Mete Baba, Deniz Seçkin
- Incidence and risk of xerosis with targeted anticancer therapies
- Johannah Valentine, Viswanath Reddy Belum, Juanita Duran, Kathryn Ciccolini, Katja Schindler, Shenhong Wu, Mario E. Lacouture
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?